Frontlight ResearchEarly access
Trial site
Dallas Diabetes Research Center
- 3running trials
- 11closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Type 2 diabetes8 trials
- Obesity4 trials
- Fatty liver disease (MASLD/MASH)3 trials
- Type 1 diabetes2 trials
- Heart failure1 trial
- Phase
- Phase 39 trials
- Phase 24 trials
- Phase 41 trial
- Status
- Completed11 trials
- Active, not recruiting3 trials
- Lead sponsor
- Eli Lilly and Company10 trials
- Applied Therapeutics, Inc.1 trial
- Inventiva Pharma1 trial
- Ionis Pharmaceuticals, Inc.1 trial
- Shionogi1 trial
Running trials
Active, not recruiting
Active, not recruiting
Active, not recruiting
Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy
Closed trials
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
A Study to Assess the Safety, Efficacy, and Pharmacokinetics of Multiple Doses of ION224
Completed
Completed
A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight
Completed
A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH)
Site data: ClinicalTrials.govUpdated 14 Nov 2026